Navigation Links
Tata Memorial Centre Wins Global Award For Fighting Cancer

The Tata Memorial Centre in Mumbai has won the 2006 global award as the "Outstanding Cancer Organisation" for its excellence in cancer control within and beyond India's borders//.

The award for the Tata Memorial Centre was presented during the annual meeting of the International Union for Cancer Control in Washington DC.

The Tata Memorial Hospital was initially set up by the Sir Dorabji Tata Trust in February 1941.

In 1952, the Indian Cancer Research Centre was established as a pioneer institute for basic research on the disease.

The Tata Memorial Hospital and Cancer Research Institute merged as the two arms of the Tata Memorial Centre in 1966 as a classic example of private philanthropy augmented by government support.

The Centre has functioned as an organization of the Department of Atomic Energy since 1962.

Accepting the honour, Ketayun A Dinshaw, Director of the Tata Memorial Centre, said it was a recognition of the outstanding commitment, team-work and dedication of all staff members of the Centre to remove the shadow of cancer from many lives for over six and half decades.

India could well be considered as a role model in cancer control for many other countries, he said.

In a message, Prime Minister Manmohan Singh congratulated the centre for the honour.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
2. Upcoming Hemogenomics Centre in Bangalore
3. International Osteoporosis Research Centre To Be Started In India.
4. New Bioinformatics Centre to open in Andhra
5. High Court Issues Notice To Centre On Smoking Ban In Films
6. Poultry Deaths, Farmers Rush To Vet Centres in Tamil Nadu
7. AIDS Assessment Centres To Be Increased In The Country
8. Diagnostic Centre Inaugurated for Air Pollution at SRMC
9. Radiation Overdose at the Beatson Oncology Centre
10. Medical Centre Opened In Tsunami-Hit Village
11. Centre Concerned over Spurt in Polio Cases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... , ... May 26, 2017 , ... ... of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface ... browser-based interface for diagnostic device operations. With this platform, initializing devices and importing ...
(Date:5/26/2017)... ... May 26, 2017 , ... Boar’s Head ... bold recipes for Memorial Day entertaining that are sure to satisfy your guests’ ... fresh sliced meats and cheeses featured in these refreshingly balanced recipes are packed ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... On May ... (AHCA), which narrowly passed the U.S. House on May 4, would result in 23 ... expected under continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... week that is focusing on the Peace Agreements being discussed by President Donald Trump ... in a race to try to speed up peace talks in the continuous battle ...
(Date:5/26/2017)... ... ... Rob Lowe acts as host and helps educate and inform the public using the ... can reconnect with America as it explores some of the best places to hike ... an inventive new place for a family vacation, and have discovered hiking. Many will ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... , May 17, 2017  Bayer announced today that ... will be presented at the 53 rd Annual ... taking place June 2-6 in Chicago ... ASCO span prostate, colorectal, liver and thyroid cancers, as ... the Phase II CHRONOS-1 trial of copanlisib in patients ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: